Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Cloudberry Clean Energy ASA | Transactions made under the share buy-back programme

Oslo, 11 December. On October 31 Cloudberry Clean Energy ASA (“Cloudberry”) announced its decision to initiate a share buy-back programme.· The duration of the buy-back programme:  31 October 2023 until 31 December 2023 at the latest. · Size of the buy-back programme: Up to 3,000,000 shares, with a maximum total consideration of NOK 43,800,000. · During week 49 2023, Cloudberry purchased 259,630 own shares at an average price of NOK 9.9384 per share. Below is an overview of the transactions carried out under the buy-back programme. Date                                      |

Today, the subscription period in Genetic Analysis subsequent offering begins

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA, BELARUS OR IN ANY OTHER JURISDICTION WHERE THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES BEYOND THOSE REQUIRED BY SWEDISH OR NORWEGIAN LAW. Today, December 11, 2023, the subscription period begins in Genetic Analysis AS' (“GA” or the “Company”) subsequent offering with gross proceeds of

STENOCARE Executive team to exercise TO1 Warrants

STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER:  STENO STENOCARE A/S (Stenocare) is currently offering new shares at a discounted rate of DKK 2.11 for TO1 Warrant owners and, through the acquisition of Warrants, new investors. Today, members of the Stenocare Executive Team have committed to exercise their TO1 Warrants thus acquiring 6% of the new shares in this transaction.The offer: Stenocare completed a Share Issue in June 2023 that was subscribed with 127%. The participants also received additional rights to purchase more Stenocare shares at a discounted price during

Insider information: Wetteri acquires Suvanto Trucks Oy through a 100% share exchange, builds a nationwide sales network for used heavy vehicles

Wetteri Plc  Insider information 11 December 2023, 9.00 EETWetteri, an entrepreneur-driven growth company in the automotive sector, will acquire Suvanto Trucks Oy through a 100% share exchange. This is the fourth acquisition in the series. Suvanto Trucks Oy operates in commercial trucks trade and maintenance in Turku, Tampere and Vantaa. The company also has operations in northern Finland. Suvanto Trucks Oy is one of Finland’s largest sellers of used heavy vehicles. The company also serves as a dealer of DAF and Sisu vehicles. Its revenue amounted to around EUR 30 million in the 2022

Stockholm International Film Festival becomes new Skandia Theater tenant

The legendary Skandia Theater on Drottninggatan in central Stockholm will continue to operate as a cinema when the premises changes tenants next year. Hufvudstaden has signed a lease with the Stockholm International Film Festival, which will take over the cinema on February 1st 2024.It has now been confirmed that the Stockholm International Film Festival will take over Skandia Theater’s premises in early 2024. In addition to organising a range of film festivals, the foundation hopes to put on film screenings on a regular basis.   “Since 1990, the Stockholm International Film Festival’

Åsa Hedin declines re-election as Chair of the Board of Tobii Dynavox

Åsa Hedin, Chair of the Board of Tobii Dynavox AB, has today informed the Nomination Committee that she will not stand for re-election at the Annual General Meeting 2024. The Nomination Committee has therefore initiated the recruitment of her successor. ” I took on the role of Chair of the Board when we separated out and listed Tobii Dynavox. My task was to create a stable foundation and conditions for continued growth. We have really succeeded in achieving these goals. Tobii Dynavox is a successful and robust company with engaged employees. Thus, now is an appropriate time for me to

Readly launches AI-powered audio for articles

Magazine and newspaper app Readly is launching audio functionality in the app to enhance the accessibility and convenience of consuming the 7600 titles on the platform. The first phase is released for British subscribers who are able to turn on an audio player for selected articles to listen to text through an AI-powered voice.– We strive to provide our readers with an increasing convenience level, enabling them to effortlessly access and enjoy captivating stories, intriguing articles, and thought-provoking editorials. Our goal is to boost user engagement and adding audio facilitates an

Tuomas Oijala starts as CEO

SPINNOVA PLC, COMPANY RELEASE 11 DECEMBER 2023 AT 08:00 A.M. EET Tuomas Oijala starts as CEO Tuomas Oijala starts today as the new CEO of Spinnova Plc. He was appointed CEO on 31 August 2023, effective as of 1 January 2024 at the latest. Spinnova Plc For further information, please contact:Virva VesanenHead of Investor RelationsTel. +358 20 703 2430ir@spinnova.fi Certified advisor:Aktia Alexander Corporate Finance OyTel. +358 50 520 4098 Distribution:Nasdaq HelsinkiMajor media  SPINNOVA – Sustainable textile materials, naturally Spinnova transforms

BerGenBio Announces Final Bemcentinib Phase 2 Data in AML and MDS Presented at the 2023 ASH Meeting

· Bemcentinib is an oral highly selective AXL inhibitor in development for cancer and severe respiratory infections · Final Phase 2 data indicates a favorable safety profile with promising efficacy in AML and MDS patients   BERGEN, Norway, December 11, 2023, – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, today announced that a poster highlighting final results from a Phase 2 clinical study of its highly selective AXL inhibitor bemcentinib in patients with Acute Myeloid

Successful leaders prioritize mental health to enhance workplace productivity and prevent costly human and financial setbacks

81% of employees feel at risk of burnout.* European studies show that mental health prevention gives over 13 times the ROI. Productivity increases by at least 20% for the majority of companies implementing EQ programs.Join EQ Europe´s  event to learn not only why it is necessary for organizations to prioritize and raise awareness about mental health but also how to do it. Date: Feb 1st Location: Stockholm,

Safety is a Catalyst for Decarbonization Innovation, ABS Chairman and CEO Tells COP28

Explicit and Systems-Oriented Approach to Safety Required Says Christopher J. Wiernicki(DUBAI) “Safety is not merely a box to check but a dynamic force shaping the trajectory of our industry. It acts as both a boundary condition, defining the limits within which we operate, and a catalyst for change, propelling us toward innovative solutions and practices that align with our commitment to a greener future.” That was the message to shipping industry leaders at COP28 from ABS Chairman and CEO Christopher J. Wiernicki. Speaking at the International Chamber of Shipping Shaping the Future

Fire at Elkem Salten

A fire broke out this afternoon at Elkem’s silicon plant in Salten, Norway, and emergency services have been mobilised. Four individuals have been transported to the local health services. Their conditions are not critical. The fire is still ongoing, but under control.“Health, safety and the environment are our first priorities. All personnel are now accounted for, and we are following up the four colleagues who have been sent to the local health services for check-ups. In addition, we have halted all production and are doing our utmost to assist the emergency services,” says Ove Sørdahl,

Nordea Bank Abp: Repurchase of own shares on 08.12.2023

Nordea Bank AbpStock exchange release – Changes in company’s own shares08.12.2023 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 08.12.2023 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |51,851 |10.70 |554,873.11

Rightbridge Ventures divests portfolio company Knacks for 4,350 PLN and saves 450,000 SEK in short-term financing

Rightbridge Ventures Group AB (publ) (“Rightbridge”) or (“The Company”) has today entered into an agreement to divest all shares in Knacks SP. Z O.O (“Knacks”) to Dawid Szymański, who is a minority shareholder in Knacks. The purchase price amounts to 4,350 PLN. The sale of Knacks results in a write-down in the wholly-owned subsidiary Rightbridge Ventures AB of approximately 3 MSEK.The Board of Rightbridge, along with management, has during November and December conducted a review of the operations to streamline the portfolio to become an investment company focused on investments and

Extraordinary General Meeting held in Ranplan Group AB

At the extraordinary general meeting in Ranplan Group AB (publ), reg. no. 559152-5315, held on 8 December 2023 in Stockholm, it was resolved that the proposed Set-Off Issue be carried out. The resolution was made in accordance with the proposal which has been made available before the extraordinary general meeting in accordance with applicable rules, see press releases Ranplan Group AB intends to implement a Set-Off Issue and Convening Notice for extraordinary general meeting in Ranplan Group AB, both published on 13 November 2023. Once the Set-Off Issue has been completed, subject to

BerGenBio ASA: Grant of share options

Bergen, Norway, 8 December 2023 – BerGenBio ASA (the “Company”) (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, today announce that the Board of Directors has granted options to employees.   The annual general meeting in the Company on 22 May 2023 approved the share option program and authorised the board of directors of the Company to issue up to 129,090,000 share options to the Company’s employees as part of a long-term incentive plan.   Options granted under the share option program will

Ecomotus’ EcoPro Fuel Catalyst System awarded RINA’s Full Type Approval

Genoa (Italy), 7 December 2023 - Full Type Approval has been granted by RINA, the inspection, certification and consulting engineering multinational, for the EcoPro Fuel Catalyst System, a standalone retrofit design that uses hydrogen to reduce emissions and improve fuel efficiency on marine engines.The EcoPro system intelligently optimises the engine’s fuel combustion, continuously monitoring engine requirements and ensuring that very specific quantities of hydrogen are produced at exactly the moment that the engine requires it.  This smart control enables owners to utilise hydrogen to

Vår Energi ASA: Shares allocated to primary insider Nick Walker as part of the long-term incentive program

Sandnes, Norway, 8 December 2023: As part of Vår Energi ASA’s (OSE: VAR) long-term incentive program for executive management, Nick Walker has been allocated 109 372 shares at an average price of 31.6743 NOK. Under the program, the CEO can be awarded between 50-150% of the base salary in restricted shares. The restricted shares have a vesting period of three years. Following the purchase Nick Walker holds a total of 481 185 shares in Vår Energi ASA Details on the purchase of shares is included in the attached notification of trading. About Vår Energi Vår Energi is a leading

DNB Bank ASA – status of share buy-back programme after week 49 2023

On 19 October 2023, DNB Bank ASA (“DNB”) announced that the company has decided to initiate a share buy-back programme comprising up to 1.0 percent of the company’s own shares, which represents a total of 15,426,132 shares. Up to 10,181,247 shares will be purchased on trading venues by 30 January 2024, and a proposal to cancel the shares will be made at the Annual General Meeting in 2024. At the same meeting it will also be proposed to redeem the remaining shares – up to 5,244,885 shares – from the Norwegian Government, represented by the Ministry of Trade, Industry and Fisheries (“NFD”),

#23-385 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

There are no items matching the current filter
There are no more items matching the current filter
Back to top